ArticleInvestigative ophthalmology & visual science2026
Enhanced Endocytosis and Mitochondrial Stress Underlie Severe Retinitis Pigmentosa With RHO P347L Mutant.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: RHO mutations are the primary cause of autosomal dominant retinitis pigmentosa (adRP), with Class 1 mutations typically exhibiting more severe phenotypes than Class 2. This study aims to clarify the mechanistic basis for this clinical disparity by systematically comparing protein degradation pathways, mitochondrial stress, and neuroinflammation. Methods: Humanized mouse lines carrying Class 1 (P347L) or Class 2 (L125R) RHO mutations were generated via CRISPR/Cas9-mediated knock-in. Retinal function, ultrastructure, and transcriptomic profiles were characterized through electroretinography (ERG), transmission electron microscopy (TEM), and RNA-sequencing (RNA-seq). To further elucidate molecular mechanisms, protein trafficking and degradation pathways were analyzed in transfected HEK293T cells using HiBiT extracellular quantification, pharmacological inhibition of lysosomal and proteasomal pathways, and BRET2 visual arrestin recruitment assay. Results: The P347L mutant failed to undergo efficient outer-segment-directed trafficking and was predominantly degraded via the lysosomal pathway, consistent with its enhanced visual arrestin recruitment and endocytosis. In contrast, the L125R mutant showed protein misfolding and was degraded by both proteasomal and lysosomal pathways. In vivo, P347L mice exhibited more pronounced mitochondrial dysfunction than L125R mice, accompanied by elevated cGMP levels and lysosomal overload. Neuroinflammation was similarly present in both mutants, indicating a shared pathological mechanism rather than a differential contributor. Conclusions: We propose a pathogenic model in which elevated endocytosis and mitochondrial dysfunction contribute to the accelerated photoreceptor degeneration in RHO P347L-associated adRP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.